NCT06455592 Effect of APA on Sleep Quality in Children With Cancer From 5 to 16 Years
| NCT ID | NCT06455592 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Clermont-Ferrand |
| Condition | Child, Only |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-11-17 |
| Primary Completion | 2027-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-11-17 with a primary completion date of 2027-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Main objective : Evaluate the effect of adapted physical activity on the sleep of children with cancer from 5 to 16 Hypothesis : Practice daily adapted physical activity improve the sleep of the 5 to 16 children with cancer
Eligibility Criteria
Inclusion Criteria: * Children from 5 to 16 with haematological cancer undergoing treatment * Subjects and their parents who were informed about the study and gave informed consent. * Enrollment in the Social Security system Exclusion Criteria: * Children on high-dose corticosteroids * Children under anxiolytic treatment * Children with sleep disorders (sleep apnea) * Children taking melatonin or sleeping pills * Contraindication to adapted physical activity * Refusal to participate on the part of the participant or his/her parents * Holders of parental authority under curatorship, guardianship, safeguard of justice * Pregnant or breast-feeding teenagers
Contact & Investigator
Emmanuelle LABRAISE
PRINCIPAL INVESTIGATOR
University Hospital, Clermont-Ferrand
Frequently Asked Questions
Who can join the NCT06455592 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, up to 16 Years, studying Child, Only. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06455592 currently recruiting?
Yes, NCT06455592 is actively recruiting participants. Contact the research team at promo_interne_drci@chu-clermontferrand.fr for enrollment information.
Where is the NCT06455592 trial being conducted?
This trial is being conducted at Clermont-Ferrand, France.
Who is sponsoring the NCT06455592 clinical trial?
NCT06455592 is sponsored by University Hospital, Clermont-Ferrand. The principal investigator is Emmanuelle LABRAISE at University Hospital, Clermont-Ferrand. The trial plans to enroll 30 participants.